NTN4 siRNA treated melanoma cells from LM-MEL-44 and -53 predominantly remain at the site of injection and demonstrated a significant reduction in emigration from the neural tube in vivo into the surrounding tissue in the embryo in whole mount and cross-sections (Figure 7A–7B). This evidence concerns the gene NTN4 and melanoma.